KYV-101 demonstrated significant efficacy in reducing MG-ADL and QMG scores in gMG patients, with rapid and sustained effects ...

Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. Each human is a ...

(RTTNews) - Kyverna Therapeutics Inc. (KYTX) has announced positive interim data from the phase 2 portion of its phase 2/3 trial of lead investigational drug KYV-101 in generalized myasthenia gravis, ...

Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg. They are coaxing clusters of stem cells – programmable cells that can transform into ...

Scientists have designed a way to 'cloak' proteins in a generalized technique that could lead to repurposing things like antibodies for biological research and therapeutic applications. Cornell ...

In healthy brains, synaptic vesicles, or message-carrying bubbles within brain cells, help transfer information from cell to ...

Kyverna Therapeutics has reported deep, sustained improvements in autoimmune disease patients who received a single dose of its CAR T-cell therapy KYV-101. The data come from the phase 2 part of a ...

Scientists have discovered a method of helping human stem cells thrive in an animal embryo—a key development in efforts to ...

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) on Tuesday revealed 12-month efficacy and safety data from the Phase 2b trial of Descartes-08, lead cell therapy candidate, in participants with generalized ...